Sammamish, WA, United States of America

Benjamin W Dulken

This inventor holds 2 USPTO granted patents. Top assignees: Omeros Corporation, University of Washington. Active years: 2016-2017.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Seattle, WA (US) (2016)
  • Sammamish, WA (US) (2017)

Company Filing History:


Years Active: 2016-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Benjamin W Dulken

Introduction

Benjamin W Dulken is an accomplished inventor based in Sammamish, WA (US). He has made significant contributions to the field of therapeutic and imaging agents through his innovative work. With a total of 2 patents, Dulken's inventions reflect his dedication to advancing medical technology.

Latest Patents

Dulken's latest patents focus on mixed micelle compositions. These compositions are designed for the administration of therapeutic agents or imaging agents to a subject. His work in this area demonstrates a commitment to improving the efficacy of drug delivery systems.

Career Highlights

Throughout his career, Benjamin W Dulken has worked with notable organizations, including Omeros Corporation and the University of Washington. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Dulken has collaborated with esteemed colleagues such as Wayne Richard Gombotz and Suzie H Pun. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Benjamin W Dulken's contributions to the field of mixed micelle compositions highlight his innovative spirit and commitment to advancing medical technology. His work continues to influence the development of therapeutic and imaging agents, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…